Bobbi Jo Van Lent, PLADC | |
Po Box A, Winnebago, NE 68071-0841 | |
(402) 878-2480 | |
(402) 878-2204 |
Full Name | Bobbi Jo Van Lent |
---|---|
Gender | Female |
Speciality | Counselor - Addiction (substance Use Disorder) |
Location | Po Box A, Winnebago, Nebraska |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1295027068 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YA0400X | Counselor - Addiction (substance Use Disorder) | P-826 (Nebraska) | Primary |
Mailing Address | Practice Location Address |
---|---|
Bobbi Jo Van Lent, PLADC Po Box A, Winnebago, NE 68071-0841 Ph: (402) 878-2480 | Bobbi Jo Van Lent, PLADC Po Box A, Winnebago, NE 68071-0841 Ph: (402) 878-2480 |
News Archive
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, despite increased competition from several emerging agents, GlaxoSmithKline's Advair will remain surveyed pulmonologists' and primary care physicians' (PCPs) favored fixed-dose long-acting beta2 agonist (LABA)/inhaled corticosteroid (ICS) combination inhaler through 2013 for the treatment of asthma and chronic obstructive pulmonary disease (COPD).
The patient in the study was the first case of gastric carcinosarcoma obtained in this part of the world . The patient was admitted by Dr. Tomislav Randjelovic as surgeon and Dr. Branka Filipovic as gastroenterologist.
The first study to investigate risk factors for the vascular condition called CCSVI (chronic cerebrospinal venous insufficiency) in volunteers without neurological disease has identified what the researchers call a remarkable similarity between this condition and possible or confirmed risk factors for multiple sclerosis.
This study conducted on a sample of 20,625 employees of the French national gas and electricity companies demonstrates that being depressed and hostile increases the mortality risk.
Neem Biotech, a Wales-based R&D biotech working in the field of novel antimicrobial drug development, announced today that it will be presenting results of its ongoing development work into the impact of NX-AS-401, its lead candidate,on biofilms in chronic cystic fibrosis lung infections at the 15th European Cystic Fibrosis Basic Science Conference taking place from 21st to 24th March 2018 in LoutrakiKorinthias, Greece.
› Verified 1 days ago
Jillian Angeline Kelsey-berridge, BS, PLADC Counselor Medicare: Not Enrolled in Medicare Practice Location: Hwy 77/75, Winnebago, NE 68071 Phone: 402-878-2480 Fax: 402-878-2204 | |
Mr. Todd Daniel Baier, PLMHP, PLADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 100 Bluff Ave, Winnebago, NE 68071 Phone: 402-878-2911 | |
Lacee Murtaugh, PLMHP Counselor Medicare: Not Enrolled in Medicare Practice Location: 100 Bluff Ave, Winnebago, NE 68071 Phone: 402-878-2911 Fax: 402-878-2027 | |
Angela Rebecca Mcelmuray Dundee, PLMHP, PMSW, LSMW Counselor Medicare: Not Enrolled in Medicare Practice Location: Augustine Dr #2, Winnebago, NE 68071 Phone: 402-878-2046 Fax: 402-878-2065 | |
Karen Ann Oaks, LMHP, LPC Counselor Medicare: Not Enrolled in Medicare Practice Location: Hwy 77/75, Ihs Hospital, Winnebago, NE 68071 Phone: 402-878-2911 Fax: 402-878-2027 | |
Gwendolyn Porter, Counselor Medicare: Not Enrolled in Medicare Practice Location: Augustine Dr. #2, Winnebago, NE 68071 Phone: 402-878-2046 |